Reg 74(5) Compliance Certificate for Quarter Ended Sep 30 2026

Compliance View source PDF Explain this filing

ARTEMISMED · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-0.2%Reaction day

₹318.80

prior close

₹316.00

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-0.2%+0.0% vs market

Hospital peers, median of 26sector-0.3%+0.1% vs sector

On the reaction day the stock moved in line with Nifty Microcap 250 and 0.1 pts more than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+1.9

10m

+1.2

15m

+0.8

30m

+1.5

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-0.2-0.2+0.0-0.3+0.1

Next day

-3.1-3.0-0.1-2.7-0.4

-1.8-2.7+0.9-1.4-0.4

-2.6-1.9-0.7-1.4-1.2

-2.4-1.7-0.6-3.2+0.9

-5.1-1.0-4.1-2.4-2.7

-4.2-2.0-2.2-3.3-0.8

15d

—————

UpDownMarket · Nifty Microcap 250Sector · Hospital peers, median of 26Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Artemis Medicare Services filed a routine compliance certificate under SEBI Regulation 74(5) for the quarter ended September 30, 2026. Registrar Alankit Assignments confirmed that physical share certificates received for dematerialization have been listed on stock exchanges, mutilated, cancelled, and the depository substituted as the registered owner. This is a standard quarterly procedural filing with no material business impact.

Likely market impact

Routine regulatory compliance filing. No material impact on shareholders or stock price.